These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1599928)

  • 21. The molecular architecture of human complement component C6.
    DiScipio RG; Hugli TE
    J Biol Chem; 1989 Sep; 264(27):16197-206. PubMed ID: 2789218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Properties of a purified pore-forming protein (perforin 1) isolated from H-2-restricted cytotoxic T cell granules.
    Young JD; Podack ER; Cohn ZA
    J Exp Med; 1986 Jul; 164(1):144-55. PubMed ID: 2425027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance to the pore-forming protein of cytotoxic T cells: comparison of target cell membrane rigidity.
    Ojcius DM; Jiang SB; Persechini PM; Storch J; Young JD
    Mol Immunol; 1990 Sep; 27(9):839-45. PubMed ID: 2215476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation of a lytic, pore-forming protein (perforin) from cytolytic T-lymphocytes.
    Masson D; Tschopp J
    J Biol Chem; 1985 Aug; 260(16):9069-72. PubMed ID: 3874868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociation of membrane binding and lytic activities of the lymphocyte pore-forming protein (perforin).
    Young JD; Damiano A; DiNome MA; Leong LG; Cohn ZA
    J Exp Med; 1987 May; 165(5):1371-82. PubMed ID: 3494808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Channel formation and [Ca2+]i accumulation induced by perforin N-terminus peptides: comparison with purified perforin and whole lytic granules.
    Binah O; Liu CC; Young JD; Berke G
    Biochem Biophys Res Commun; 1997 Nov; 240(3):647-50. PubMed ID: 9398619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium is essential for both the membrane binding and lytic activity of pore-forming protein (perforin) from cytotoxic T-lymphocyte.
    Ishiura S; Matsuda K; Koizumi H; Tsukahara T; Arahata K; Sugita H
    Mol Immunol; 1990 Aug; 27(8):803-7. PubMed ID: 2402247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A calcium- and perforin-independent pathway of killing mediated by murine cytolytic lymphocytes.
    Young JD; Clark WR; Liu CC; Cohn ZA
    J Exp Med; 1987 Dec; 166(6):1894-9. PubMed ID: 3500267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dependence of the lytic activity of the N-terminal domain of human perforin on membrane lipid composition--implications for T-cell self-preservation.
    Rochel N; Cowan JA
    Eur J Biochem; 1997 Oct; 249(1):223-31. PubMed ID: 9363773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The homologous restriction factor is immunologically related to complement components C8 and C9 and to lymphocyte pore-forming protein perforin through cysteine-rich domains.
    Young JD; Rosse WF; Hasselkus-Light CS
    Biochem Biophys Res Commun; 1990 Jan; 166(2):648-52. PubMed ID: 2302230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the lytic activity of perforin by lipoproteins.
    Tschopp J; Masson D; Schäfer S
    J Immunol; 1986 Sep; 137(6):1950-3. PubMed ID: 2427587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular release of lymphocyte cytolytic pore-forming protein (perforin) after ionophore stimulation.
    Young JD; Leong LG; Liu CC; Damiano A; Cohn ZA
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5668-72. PubMed ID: 2426703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Channel-forming proteins of man and amoebae.
    Müller-Eberhard HJ
    Behring Inst Mitt; 1992 Apr; (91):138-44. PubMed ID: 1381916
    [No Abstract]   [Full Text] [Related]  

  • 34. Phosphorylcholine acts as a Ca2+-dependent receptor molecule for lymphocyte perforin.
    Tschopp J; Schäfer S; Masson D; Peitsch MC; Heusser C
    Nature; 1989 Jan; 337(6204):272-4. PubMed ID: 2783478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perforin binding to cells and lipid membranes determined by a simple competition assay.
    Jiang SB; Ojcius DM; Young JD
    J Immunol Methods; 1990 Jan; 126(1):29-37. PubMed ID: 2303723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
    Jiang S; Persechini PM; Perussia B; Young JD
    J Immunol; 1989 Sep; 143(5):1453-60. PubMed ID: 2503557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules.
    Podack ER; Young JD; Cohn ZA
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8629-33. PubMed ID: 2417226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and characterization of functionally active recombinant perforin produced in insect cells.
    Liu CC; Persechini PM; Young JD
    J Immunol; 1996 May; 156(9):3292-300. PubMed ID: 8617952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domain.
    Uellner R; Zvelebil MJ; Hopkins J; Jones J; MacDougall LK; Morgan BP; Podack E; Waterfield MD; Griffiths GM
    EMBO J; 1997 Dec; 16(24):7287-96. PubMed ID: 9405358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A microassay for the pore-forming activity of complement, perforin, and other cytolytic proteins based on confocal laser scanning microscopy.
    Sauer H; Pratsch L; Peters R
    Anal Biochem; 1991 May; 194(2):418-24. PubMed ID: 1862943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.